» Articles » PMID: 2247599

Biological Consequence of Nuclear Versus Cytoplasmic Decays of 125I: Cysteamine As a Radioprotector Against Auger Cascades in Vivo

Overview
Journal Radiat Res
Specialties Genetics
Radiology
Date 1990 Nov 1
PMID 2247599
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

When the radionuclide 125I is localized in mouse testis as 125I-iododeoxyuridine (an analogue of thymidine) and incorporated into the DNA of spermatogonial cells, the cytocidal effects are as severe as those due to densely ionizing alpha particles. In contrast, 125I confined to the cytoplasm of these cells is much less radiotoxic, the efficacy being the same as for selective irradiation of the testis with sparsely ionizing external X rays. The biological effects, in both cases, are strongly mitigated upon pretreatment of the testes with very small amounts (0.75 microgram) of cysteamine, a radioprotector. These findings suggest an important role for such chemical agents in radiation protection and in understanding the mechanisms of radiation damage involving radionuclides incorporated in tissue.

Citing Articles

Can Radionuclide Therapy be the Solution for Hepatitis B Virus Infection?.

Sung P, Yoo I Nucl Med Mol Imaging. 2024; 58(5):255-257.

PMID: 39036462 PMC: 11255138. DOI: 10.1007/s13139-024-00862-5.


Auger electrons for cancer therapy - a review.

Ku A, Facca V, Cai Z, Reilly R EJNMMI Radiopharm Chem. 2019; 4(1):27.

PMID: 31659527 PMC: 6800417. DOI: 10.1186/s41181-019-0075-2.


Amino acids and their derivatives as radioprotective agents.

Roberts J Amino Acids. 2013; 3(1):25-52.

PMID: 24192988 DOI: 10.1007/BF00806007.


Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells.

Neti P, Howell R J Nucl Med. 2004; 45(6):1050-8.

PMID: 15181140 PMC: 2911233.


Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I.

Howell R, Bishayee A Micron. 2001; 33(2):127-32.

PMID: 11567881 PMC: 3040493. DOI: 10.1016/s0968-4328(01)00007-5.